Catatonia in depression: Prevalence, clinical correlates, and validation of a scale

Objectives - To examine the clinical correlates of catatonia in depression, to validate a scale for catatonia, and to assess the validity of the DSM-IV criteria of the catatonic features specifier for mood disorders. Methods - series of 79 consecutive patients with depression and 41 patients with Pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 1996
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00223050_v60_n3_p326_Starkstein
http://hdl.handle.net/20.500.12110/paper_00223050_v60_n3_p326_Starkstein
Aporte de:
id paper:paper_00223050_v60_n3_p326_Starkstein
record_format dspace
spelling paper:paper_00223050_v60_n3_p326_Starkstein2023-06-08T14:49:08Z Catatonia in depression: Prevalence, clinical correlates, and validation of a scale Catatonia Depression Dopamine Parkinson's disease apomorphine domperidone adult aged article catatonia cognitive defect comparative study daily life activity depression human major clinical study Parkinson disease prevalence priority journal rating scale Objectives - To examine the clinical correlates of catatonia in depression, to validate a scale for catatonia, and to assess the validity of the DSM-IV criteria of the catatonic features specifier for mood disorders. Methods - series of 79 consecutive patients with depression and 41 patients with Parkinson's disease without depression were examined using the modified Rogers scale (MRS), the Parkinson's disease rating (UPDRS), and the structured clinical interview for DSM-III-R (SCID). Results - Sixteen of the 79 depressed patients (20%) had catatonia. Depressed patients with catatonia had significantly higher scores on the MRS than non-catatonic depressed patients matched for severity of depression, or non-depressed patients with Parkinson's disease matched for severity of motor impairment. Depressed patients with catatonia were older, had a significantly higher frequency of major depression, more severe cognitive impairments, and more severe deficits in activities of daily living than depressed non-catatonic patients. The DSM-IV criteria of catatonia separated catatonic patients from with Parkinson's disease matched for motor impairment, with a specificity of 100%. Catatonic signs did not improve after apomorphine. Conclusions - catatonia is most prevalent among elderly patients with severe depression. The study showed the validity of the MRS for the diagnosis of catatonia in depressed patients, as well as the specificity of the DSM-IV criteria of the catatonic features specifier. 1996 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00223050_v60_n3_p326_Starkstein http://hdl.handle.net/20.500.12110/paper_00223050_v60_n3_p326_Starkstein
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Catatonia
Depression
Dopamine
Parkinson's disease
apomorphine
domperidone
adult
aged
article
catatonia
cognitive defect
comparative study
daily life activity
depression
human
major clinical study
Parkinson disease
prevalence
priority journal
rating scale
spellingShingle Catatonia
Depression
Dopamine
Parkinson's disease
apomorphine
domperidone
adult
aged
article
catatonia
cognitive defect
comparative study
daily life activity
depression
human
major clinical study
Parkinson disease
prevalence
priority journal
rating scale
Catatonia in depression: Prevalence, clinical correlates, and validation of a scale
topic_facet Catatonia
Depression
Dopamine
Parkinson's disease
apomorphine
domperidone
adult
aged
article
catatonia
cognitive defect
comparative study
daily life activity
depression
human
major clinical study
Parkinson disease
prevalence
priority journal
rating scale
description Objectives - To examine the clinical correlates of catatonia in depression, to validate a scale for catatonia, and to assess the validity of the DSM-IV criteria of the catatonic features specifier for mood disorders. Methods - series of 79 consecutive patients with depression and 41 patients with Parkinson's disease without depression were examined using the modified Rogers scale (MRS), the Parkinson's disease rating (UPDRS), and the structured clinical interview for DSM-III-R (SCID). Results - Sixteen of the 79 depressed patients (20%) had catatonia. Depressed patients with catatonia had significantly higher scores on the MRS than non-catatonic depressed patients matched for severity of depression, or non-depressed patients with Parkinson's disease matched for severity of motor impairment. Depressed patients with catatonia were older, had a significantly higher frequency of major depression, more severe cognitive impairments, and more severe deficits in activities of daily living than depressed non-catatonic patients. The DSM-IV criteria of catatonia separated catatonic patients from with Parkinson's disease matched for motor impairment, with a specificity of 100%. Catatonic signs did not improve after apomorphine. Conclusions - catatonia is most prevalent among elderly patients with severe depression. The study showed the validity of the MRS for the diagnosis of catatonia in depressed patients, as well as the specificity of the DSM-IV criteria of the catatonic features specifier.
title Catatonia in depression: Prevalence, clinical correlates, and validation of a scale
title_short Catatonia in depression: Prevalence, clinical correlates, and validation of a scale
title_full Catatonia in depression: Prevalence, clinical correlates, and validation of a scale
title_fullStr Catatonia in depression: Prevalence, clinical correlates, and validation of a scale
title_full_unstemmed Catatonia in depression: Prevalence, clinical correlates, and validation of a scale
title_sort catatonia in depression: prevalence, clinical correlates, and validation of a scale
publishDate 1996
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00223050_v60_n3_p326_Starkstein
http://hdl.handle.net/20.500.12110/paper_00223050_v60_n3_p326_Starkstein
_version_ 1768542114760622080